MAP2K7 and breast carcinoma: Furthermore, the RAS‐RAF‐MEK‐ERK (hereafter referred to as MAPK/ERK) signaling pathway is frequently overactivated in all types of breast cancer, particularly in the molecular subtype basal‐like breast cancer.